LLY Donald A Zakrowski sells $716K worth of shares
May 28, 2025, 4:32 AM
0.00%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
Donald A Zakrowski sold 1,000 shares of LLY on 27 May at $716.41 per share, worth a total of $716K. They now own 4,840 LLY shares, or a 17% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
